AVIR

Atea Pharmaceuticals, Inc.

Halal Rating :
To Be Determined
Last Price $3.25 Last updated:
Market Cap $325.02m
7D Change 2.85%
1 Year Change 2.2%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NASDAQ
Next Earnings Date Nov. 7, 2024

Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company's primary focus has been on developing treatments for viral diseases, including COVID-19.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio

Company Impact

Help us evaluate Atea Pharmaceuticals, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates